Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1995-05-30
1998-11-03
Elliott, George G.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
4242781, 514615, 514818, A61K 4505, A61K 4800, A61K 3100
Patent
active
058308768
ABSTRACT:
A method of immunizing an individual against pathogen is disclosed. Also disclosed is a method of treating an individual who has a hyperproliferative disease, or of treating an individual who is infected by a pathogen. Specifically, the individual is injected with bupivacaine along with DNA in an expressible form, the DNA encoding an antigen. The encoded antigen can be from a protein from the pathogen or from a protein associated with the hyperproliferative disease.
REFERENCES:
patent: 4224404 (1980-09-01), Viza et al.
patent: 4394448 (1983-07-01), Szoka, Jr. et al.
patent: 4806463 (1989-02-01), Goodchild et al.
patent: 4945050 (1990-07-01), Sanford et al.
patent: 5017487 (1991-05-01), Stunnenberg et al.
patent: 5036006 (1991-07-01), Sanford et al.
patent: 5466676 (1995-11-01), Booth et al.
Saag et al., Nature Medicine 2(6):625-629 (1996).
A. M. Schultz et al., AIDS 7(suppl. 1):S161-S170 (1993).
V. Glaser, Genetic Engineering News 16(1):6 (1996).
Vandenbark, A., et al., Immunization with a synthetic T-cell receptor v-region peptide protects against experimental autoimmune encephalomyelitis, 1989 Nature 341:541-544.
McCoy, M. et al., Human Colon Carcinoma Ki-ras2 Oncogene and Its Corresponding Proto-Oncogene, 1984 Mol. Cell. Biol. 4:1577-1582.
Weiner, D.B., et al., Non-CD4 Molecules on Human Cells Important in HIV-1 Cell Entry, (1989) Vaccines, Cold Spring Harbor Press, 115-120.
Williams, W.V., et al., Molecular Diagnosis of Borrelia burgdorferi Infection (Lyme Disease), 1992 DNA and Cell. Biol. 11(3):207-213.
Williams, W.V., et al., Restricted Heterogeneity of T Cell Receptor Transcripts in Rheumatoid Synovium, 1992 J. Clin. Invest. 90:326-333.
Wolfe, J.A. et al., Direct Gene Transfer into Mouse Muscle in Vivo, (1990) Science 247:1465-1468.
Wolfe, J.A., et al., Conditions Affecting Direct Gene Transfer into Rodent Muscle In Vivo, 1991 BioTechniques 11(4):474-485.
Wucherpfennig, K.W., et al., Shares Human T Cell Receptor V.sub.B Usage to Immunodominant Regions of Myelin Basic Protein, 1990 Science 248:1016-1019.
Acsadi G., et al., Human dystrophin expression in mdx mice after intramuscular injection of DNA constructs, (1991) Nature 352:815-818.
Anilionis, A., et al., Structure of the glycoprotein gene in rabies virus, 1981 Nature 294:275-278.
Berman P.W., et al., Protection of chimpanzees from infection by HIV-1 after vaccination with recombinant glycoprotein gp120 but not gp160, (1990) Nature 345:622-625.
Chaudhary, V.K., et al., A rapid method of cloning functional variable-region antibody genes in Escherichia coli as single-chain immunotoxins, 1990 Proc. Natl. Acad. Sci. USA 87:1066-1070.
Chen, Y.H., et al., HIV-1 gp41 contains two sites for interaction with several proteins on the helper T-lymphoid cell line, H9, (1992) AIDS 6:533-539.
Cheng-Mayer, C., et al., Human immunodeficiency virus can productively infect cultured human glial cells, (1987) Proc. Natl. Acad. Sci. USA 84:3526-3530.
Crowe, J.S., et al., Improved cloning efficiency of polymerase chain reaction (PCR) products after proteinase K digestion, (1991) Nucl. Acids Res. 19;184.
Desquenne-Clark, L., et al., T-cell receptor peptide immunization leads to enhanced and chronic experimental allergic encephalomyelitis, 1991 Proc. Natl. Acad. Sci. USA 88:7219-7223.
DiFiore, erbB-2 is a Potent Oncogene When Overexpressed in NIH/3T3 Cells, 1987 Science 237:178-182.
Anderson, W. French, "Prospects for Human Gene Therapy," Science 226:401-409, 1984.
Dubensky et al., "Direct transfection of viral and plasmid DNA into the liver or spleen of mice," Proc. Natl. Acad. Sci. USA 81:7529-7533, 1984.
Israel et al., "Biological Activity of Polyoma viral DNA in Mice and Hamsters," J. of Virology 29:990-996, 1979.
Langlois et al., "The Ability of Certain SIV Vaccines to Provoke Reactions Against Normal Cells," Science 255:292-293, 1992.
Letvin et al., "Risks of Handling HIV," Nature 349:573, 1991.
Tang et al., "Genetic immunization is a simple method for eliciting an immune response," Nature 356:152-154, 1992.
Will et al., "Cloned HBV DNA causes hepatitis in chimpanzees," Nature 299:740-742, 1982.
Benoit and Belt, Destruction and regeneration of skeletal muscle after treatment with a local anaesthetic, bupivacaine (Marcaine.RTM.) J. Anat. 107:547-556, 1970.
Hall-Craggs, E.C.B., Rapid Degeneration and Regeneration of a Whole Skeletal Muscle Following Treatment with Bupivacaine (Marcaine) Experimental Neurology 43:349-358, 1974.
Felgner, P.L. and G. Rhodes, Gene therapeutics, (1991) Nature 349:351-352.
Fisher, A.G., et al., A molecular clone of HTLV-III with biological activity, (1985) Nature 316:262-265.
Fisher, R.A., et al., HIV infection is blocked in vitro by recombinant soluble CD4, (1988) Nature 331:76-78.
Goudsmit, J. et al., (1988) AIDS 2:157-164.
Hahn and Ebling, Supression of Murine Lupus Nephritis by Administration of an Anti-Idiotypic Antibody to Anti-DNA, 1984 J. Immunol. 132(1):187-190.
Howley, P., Papillomavirinae and Their Replication, 1990 Fields Virology, vol. 2, Channock, R.M., et al., Eds., Chapter 58:1625-1650.
Howell, M.D., et al., Limited T-cell receptor B-chain heterogeneity among interleukin 2 receptor-positive synovial T cells suggest a role for superantigen in rheumatoid arthritis, 1991 Proc. Natl. Acad. Sci. USA 88:10921-10925.
Klein, T.M. et al., Transformation of Microbes, Plants and Animals by Particle Bombardment, (1992) Bio/technology 10:286-291.
Koenig, S., et al., Detection of AIDS Virus in Macrophages in Brain Tissues from AIDS Patients with Encephalopathy, (1986) Science 233:1089-1093.
Kowalski, M., et al., Functional Regions of the Envelope Glycoprotein of Human Immunodeficiency Virus type 1, (1987) Science 237:1351-135.
Lasky, L.A. et al., Neutralization of the AIDS Retrovirus by Antibodies to a Recombinant Envelope Glycoportein, (1986) Science 233:209-212.
Lasky, L.A., et al., Delineation of a Region of the Human Immunodeficiency Virus Type 1 gp120 Glycoprotein Critical for Interaction with the CD4 Receptor, (1987) Cell 50:975-985.
Maddon, P.J., et al., The T4 Gene Encodes the AIDS Virus Receptor and is Expressed in the Immune System and the Brain, (1986) Cell 47:333-348.
Montefiori, D.C., Evaluation of Antiviral Drugs and Neutralizing Antibodies to Human Immunodeficiency Virus by a Rapid and Sensitive Microtiter Infection Assay, (1988) J. Clin. Microbio. 26:231-235.
Morgenstern and Land, Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line, 1990 Nucl. Acids Res. 18(12):3587-3596.
Nabel, E.G., et al., Site-Specific Gene Expression in Vivo by Direct Gene Transfer into the Arterial Wall, (1990) Science 249:1285-1288.
Nara, P., Quantitative Infectivity Syncytium-Forming Microassay, (1989) Techniques In HIV Research, Aldovini & Walker, Eds. 77-86, M Stockton Press.
Oksenberg, J.R., et al., Limited heterogeneity of rearranged T-cell receptor V a transcripts in brains of multiple sclerosis patients, 1990 Nature 345:344-346.
Osther, K., et al., Protective Humoral Immune Responses to the Human Immunodeficiency Virus Induced in Immunized Pigs: A Possible Source of Therapeutic Immunoglobulin Preparations, (1991) Hybridoma 10:673-683.
Osther, K., et al., The quick Western Blot, A Novel Transportable 50 Minute HIV-1 Antibody Test, (1989) Transplantation 47:834-8.
Paliard, X., et al., Evidence for the Effects of a Superantigen in Rheumatoid Arthritis, 1991 Science 253:325-329.
Putney, S.D., et al., AIDS The Scientific and Social Challenge, (1989) Development Of An HIV Subunit Vaccine, Montreal, V International Conference on AIDS, Abstract Th.C.O. 50.
Schrier, R.D., et al., B-and T-Lymphocyte Responses to an Immunodominant Epitope of Human Immunodeficiency Virus, (1988) J. Virol. 62:2531-2536.
Sun, H.C., et al., Generation and Characterization of Monoclonal Antibodies to the Putative CD4-Binding Domain of Human Immunodeficiency Virus Type 1 gp120, 1989 J. Virol. 63:3579-85.
Shah and Howley, Papillomaviruses, 1990 Fields Virology, Channock, R.M. et al., Eds., vol. 2, Chapter 59, pp. 1651-1676.
Seed, B. and A. Aruf
Wang Bin
Weiner David B.
Williams William V.
Elliott George G.
Railey II Johnny F.
The Trustees of the University of Pennsylvania
The Wistar Institute
LandOfFree
Genetic immunization does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Genetic immunization, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Genetic immunization will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-689261